Work

Identifying differential predictive biomarkers for anti-interleukin-6 receptor and anti-tumor necrosis factor-α in active rheumatoid arthritis: MONARCH biomarker analyses

Year: 2024

Type: conference-paper

Abstract: Introduction: The identification of predictive and pharmacodynamic biomarkers to treatment response is of utmost importance to improve clinical and economic outcomes in patients with active rheumatoid arthritis (RA) [ref:1]. Here, we identified blood-based predictive and pharmacodynamic biomarkers [for full text, please go to the a.m. URL]

Source: German Medical Science (German Research Foundation)

DOI: 10.3205/24dgrh157

Authors: Biesemann, Nadine, Agueusop, Inoncent, Margerie, Daniel, Remaury, Anne, Brard, Raphaël, Frau, Francesca, Gerard, Emilie, Thill, Gilbert, Yaligara, Veeranagouda, Didier, Michel, Kohlmann, Markus, Herrmann, Matthias

Institutions: Sanofi (Germany), Sanofi (France)

Language: English

Topic: Rheumatoid Arthritis Research and Therapies

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W6889810158

FWCI:

Cites:

Cited by:

Related to: